Cite
HARVARD Citation
Lüftner, D. et al. (n.d.). 1869 Disease characteristics of subgroup patients treated with everolimus + exemestane for <12 months, ≥12 to <18months, and ≥18 months - Results of the 3rd interim analysis of the non-interventional trial BRAWO. European journal of cancer. pp. S288-S289. [Online].